Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Acute Exacerbation of COPD
NCT05706402Phase 3Unknown
- Sponsor
- Queen Mary Hospital
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in chronic obstructive pulmonary disease (COPD), sponsored by Queen Mary Hospital. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05706402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05706402.